SANA IN A MOTHNLY DEMAND ZONEthe current price is in the monthly demand zone and the stock is expected to start and uptrend soon targeting the quarterly supply zone.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.41 USD
−283.25 M USD
0.00 USD
122.43 M
About Sana Biotechnology, Inc.
Sector
Industry
CEO
Steven D. Harr
Website
Headquarters
Seattle
Founded
2018
FIGI
BBG00N5BMH61
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
This HUGE buy makes me think the stock will go upSANA is very to close to penny stock area, but I think it will go up in medium/long term
SANA Ladies and GentlemenThe stock breaks through a resistance level today with supporting volume, weekly oscillators raise their heads
Buying - $9.7
First target - $16
Second target - $26
Not a recommendation of course
The only way to trade the stock market... continued in the signature below
NASDAQ:SANA
SANA - two scenarios to evaluateNASDAQ:SANA is offering two potential scenarios. The first is a breakout of a descending trendline after a lengthy consolidation. These are some of my favorite patterns to trade.
I'd look to take profits in 3 stages that start with the fib resistance areas and recent highs, and end with anticipa
$S AN A is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Sana Biotechnology develops in vivo and ex vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular disease
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SANA is 1.75 USD — it has increased by 7.36% in the past 24 hours. Watch Sana Biotechnology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sana Biotechnology, Inc. stocks are traded under the ticker SANA.
SANA stock has fallen by −10.26% compared to the previous week, the month change is a −26.78% fall, over the last year Sana Biotechnology, Inc. has showed a −58.03% decrease.
We've gathered analysts' opinions on Sana Biotechnology, Inc. future price: according to them, SANA price has a max estimate of 16.00 USD and a min estimate of 8.00 USD. Watch SANA chart and read a more detailed Sana Biotechnology, Inc. stock forecast: see what analysts think of Sana Biotechnology, Inc. and suggest that you do with its stocks.
SANA reached its all-time high on Feb 10, 2021 with the price of 44.60 USD, and its all-time low was 1.55 USD and was reached on Dec 19, 2024. View more price dynamics on SANA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SANA stock is 9.26% volatile and has beta coefficient of 1.41. Track Sana Biotechnology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sana Biotechnology, Inc. there?
Today Sana Biotechnology, Inc. has the market capitalization of 363.93 M, it has decreased by −14.66% over the last week.
Yes, you can track Sana Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
Sana Biotechnology, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
SANA earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.26 USD resulting in a 2.78% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Sana Biotechnology, Inc. earnings.
Sana Biotechnology, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SANA net income for the last quarter is −59.92 M USD, while the quarter before that showed −50.29 M USD of net income which accounts for −19.15% change. Track more Sana Biotechnology, Inc. financial stats to get the full picture.
No, SANA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 328.00 employees. See our rating of the largest employees — is Sana Biotechnology, Inc. on this list?
Like other stocks, SANA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sana Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sana Biotechnology, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sana Biotechnology, Inc. stock shows the sell signal. See more of Sana Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.